In Association With Scotland
Precision medicine and digital health innovation for disease diagnosis, care and treatment
Oligonucleotides: Overcoming sustainability challenges with manufacturing
Oligonucleotides have the potential to transform medical treatments for diseases such as cancer and Alzheimer’s, but many obstacles impede the scale-up of manufacturing – with sustainability a key issue. CPI’s new Oligonucleotide Manufacturing Innovation Centre of Excellence in Scotland could help to overcome many of these challenges.
How remote monitoring tech is enhancing healthcare for ageing populations
Healthtech: detecting early risks of diseases and optimising treatments
Worldwide healthtech growth: how the UK and Scotland are positioned
